CIK 0001711754 · Non-accelerated filer<br>Smaller reporting company
Inmune Bio, Inc.
Sign in to watch- Ticker
- INMB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 475205835
- Phone
- 8589643720
- Business address
- 225 NE MIZNER BLVD, SUITE 640, BOCA RATON, FL, 33432
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- PRE 14A Proxy Proxy Statement (Preliminary)
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- 8-K Event Other events
- 8-K Event Regulation FD disclosure
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- 8-K Event Regulation FD disclosure
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 8-K Event Regulation FD disclosure
Page 26 of 31 · 601 filings